SCHEMBL18925438

SCHEMBL18925438

Cn1ncc2c(Nc3nc(NC4CCCCC4N)c(C#N)cc3C(N)=O)cccc21

nearest known ligand 0.64

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ FER P16591 6/20 0.64
▸ SYK P43405 14/20 0.64

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5028014 1.00 FER (0.64) FERSYK
SCHEMBL14911035 0.89 SYK (0.67) FERSYK
SCHEMBL9108655 0.89 SYK (0.67) FERSYK
SCHEMBL18925404 0.84 FER (0.64) FERSYK
SCHEMBL5026375 0.84 FER (0.64) FERSYK
SCHEMBL2713206 0.83 SYK (0.69) FERSYK
SCHEMBL1353694 0.83 SYK (0.79) SYK
SCHEMBL14910179 0.80 SYK (0.55) SYK
SCHEMBL14909705 0.79 SYK (0.68) SYK
SCHEMBL14929170 0.79 SYK (0.68) SYK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3176154-A1 BENZAMIDES AND NICOTINAMIDES AS SYK MODULATORS Portola Pharmaceuticals, Inc. (US) 2017-06-07 — — EP disclosed
US-20150272956-A1 SUBSTITUTED XANTHINE DERIVATIVES SUN PHARMACEUTICAL INDUSTRIES, INC. 2015-10-01 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150272956-A1 SUBSTITUTED XANTHINE DERIVATIVES XDH, HPRT1, CXCR3 FER 3205/4885SYK 2450/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback